SiteOne Therapeutics Appoints John Hunter, Ph.D. as Chief Scientific Officer

BOZEMAN, Mont., Sept. 6, 2018 -- (Healthcare Sales & Marketing Network) -- SiteOne Therapeutics, a private biopharmaceutical company advancing novel non-opioid pain therapeutics, today announced the appointment of John Hunter, Ph.D., as Chief Scientific O... Biopharmaceuticals, Personnel SiteOne Therapeutics, sodium ion channel, pain therapeutic

Source: HSMN NewsFeed - September 6, 2018 Category: Pharmaceuticals Source Type: news